SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 54 filers reported holding SYNTA PHARMACEUTICALS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 1,500 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $1,000 | -66.7% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $3,000 | 0.0% | 1,500 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $3,000 | 0.0% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $3,000 | -25.0% | 1,500 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $4,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,696,894 | $7,637,000 | 32.03% |
| Anson Funds Management LP | 989,204 | $348,000 | 0.11% |
| CAXTON CORP | 62,000 | $22,000 | 0.09% |
| McQueen, Ball & Associates Inc. | 102,742 | $36,000 | 0.03% |
| Sheaff Brock Investment Advisors, LLC | 320,000 | $113,000 | 0.01% |
| Roundview Capital LLC | 21,100 | $7,000 | 0.00% |
| QCM Cayman, Ltd. | 11,197 | $4,000 | 0.00% |
| ZACKS INVESTMENT MANAGEMENT | 193,406 | $68,000 | 0.00% |
| Renaissance Technologies | 2,504,200 | $881,000 | 0.00% |
| Squarepoint Ops LLC | 56,800 | $20,000 | 0.00% |